Table 2 Median, 90th percentile and range of lipid-adjusted serum levels of polychlorinated biphenyl (PCB) congeners and total PCBs, in ng/g lipids, in HCC cases and healthy controls.
IUPAC PCB congeners | Cases (N = 62) | Controls (N = 102) | ||||
|---|---|---|---|---|---|---|
Median | 90th percentile | Range (min–max) | Median | 90th percentile | Range (min–max) | |
PCB 28 | 0 | 0 | 0–0 | 0 | 0 | 0–124 |
PCB 74 | 0 | 26 | 0–37 | 0 | 19 | 0–82 |
PCB 99 | 0 | 25 | 0–49 | 0 | 19 | 0–100 |
PCB 105 | 0 | 0 | 0–0 | 0 | 0 | 0–57 |
PCB 118 | 20.5 | 70 | 0–128 | 14.5 | 45 | 0–241 |
PCB 138 | 92.5 | 232 | 0–349 | 86 | 173 | 14–511 |
PCB 146 | 4 | 24 | 0–35 | 9 | 20 | 0–41 |
PCB 153 | 178.5 | 412 | 35–699 | 159.9 | 327 | 23–691 |
PCB 156 | 21.5 | 42 | 0–63 | 19.5 | 33 | 0–74 |
PCB 157 | 0 | 0 | 0–17 | 0 | 0 | 0–15 |
PCB 167 | 0 | 12 | 0–27 | 0 | 12 | 0–33 |
PCB 170 | 62 | 132 | 0–196 | 61 | 96 | 0–209 |
PCB 172 | 0 | 15 | 0–26 | 0 | 12 | 0–20 |
PCB 177 | 0 | 0 | 0–15 | 0 | 0 | 0–21 |
PCB 180 | 234 | 516 | 52–779 | 214.5 | 352 | 34–810 |
PCB 183 | 9.5 | 31 | 0–57 | 9 | 20 | 0–44 |
PCB 187 | 29.5 | 64 | 0–127 | 26.5 | 49 | 0–138 |
PCB 189 | 0 | 0 | 0–0 | 0 | 0 | 0–11 |
PCB 194 | 56 | 132 | 0–266 | 49 | 90 | 0–231 |
PCB 196 + 203 | 30 | 61 | 0–108 | 28.5 | 50 | 0–88 |
PCB 201 | 25.5 | 53 | 0–133 | 22 | 40 | 0–96 |
PCB 206 | 0 | 0 | 0–0 | 0 | 0 | 0–24 |
PCB 209 | 0 | 19 | 0–53 | 0 | 15 | 0–195 |
Total PCBs | 757 | 1787 | 95–2703 | 737.5 | 1365 | 92–3089 |
